Advanced biomaterials for cancer immunotherapy

Area of Science:

• Oncology
• Nanotechnology
• Immunology

Background:

• Cancer immunotherapy shows promise but requires enhanced efficacy and reduced side effects.
• Nanobiomaterials offer a strategy for codelivery of therapeutic agents and immunomodulators.
• Current challenges include optimizing delivery systems for better therapeutic outcomes.

Purpose of the Study:

• To provide an overview of recent advancements in nanobiomaterials for cancer immunotherapy.
• To highlight various nanobiomaterial systems and their roles in enhancing immune responses.
• To discuss the potential of nanobiomaterials in improving cancer treatment accuracy and efficiency.

Main Methods:

• Review of current literature on nanobiomaterials in cancer immunotherapy.
• Categorization of nanobiomaterials into lipid-based, polymer-based, and inorganic systems.
• Analysis of codelivery strategies and their impact on immune responses and toxicity.

Main Results:

• Nanobiomaterial-based delivery systems effectively promote antitumor immune responses.
• These systems can simultaneously reduce toxic adverse effects associated with immunotherapy.
• Combinations of nanobiomaterials or with traditional drugs offer precise and efficient tumor treatment.

Conclusions:

• Advanced nanobiomaterials are crucial for improving cancer immunotherapy efficacy.
• Lipid-based, polymer-based, and inorganic nanocarriers show significant potential.
• Nanobiomaterial-drug combinations represent a promising avenue for next-generation cancer therapies.